<![CDATA[Greg's Alzheimer's Research Report]]>https://gregsalzheimersresearchreport.substack.comhttps://substackcdn.com/image/fetch/$s_!nyHN!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fec3034b6-525b-42bb-ae06-ff516c4892c8_1280x1280.pngGreg's Alzheimer's Research Reporthttps://gregsalzheimersresearchreport.substack.comSubstackThu, 21 May 2026 14:32:12 GMT<![CDATA[Masitinib - Adjunct Therapy For Mild-To-Moderate Alzheimer's]]>https://gregsalzheimersresearchreport.substack.com/p/masitinib-adjunct-therapy-for-mildhttps://gregsalzheimersresearchreport.substack.com/p/masitinib-adjunct-therapy-for-mildWed, 20 May 2026 19:00:32 GMT

AB Science is developing a promising adjunct drug for treating Alzheimer’s disease (AD). The drug is known as Masitinib. This is an oral tyrosine kinase inhibitor. The target patient for Masitnib are people with mild-to-moderate AD.

Read more

]]><![CDATA[Genes Linked To Alzheimer's Disease]]>https://gregsalzheimersresearchreport.substack.com/p/genes-linked-to-alzheimers-diseasehttps://gregsalzheimersresearchreport.substack.com/p/genes-linked-to-alzheimers-diseaseTue, 19 May 2026 21:15:24 GMT

Yesterday’s article discussed the APOE genes. Today, I want to explore other genes that studies have found to be linked to late-onset Alzheimer’s disease (AD).

Read more

]]><![CDATA[Alzheimer's Genes: Are you at risk?]]>https://gregsalzheimersresearchreport.substack.com/p/alzheimers-genes-are-you-at-riskhttps://gregsalzheimersresearchreport.substack.com/p/alzheimers-genes-are-you-at-riskMon, 18 May 2026 18:09:53 GMT

Recently, there has been a lot of talk and discussion about the role family history plays in someone developing Alzheimer’s disease (AD). During my initial meeting with a neurologist at Duke Neurolog…

Read more

]]>